| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8784354 | Taiwanese Journal of Obstetrics and Gynecology | 2018 | 5 Pages |
Abstract
The data of the present study suggested that PAPP-A might be a clinical indicator in PCOS, in which the risks of metabolic syndrome and cardiovascular event are increased. Especially a group of young patients with BMI <27Â kg/m2 might benefit from the cardiovascular risk evaluation using PAPP-A, supplying prognostic information for high risk in the development of cardiovascular disease.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Merve Ãztürk, Mesut Ãktem, S. Ãzlem Altinkaya, Emel Ãzalp Ãktem, Åehri Elbeg, Ahmet Erdem, Mehmet Erdem,